| α | alpha |
| α7nAchR | α-7 Nicotinic acetylcholine receptor |
| α-syn | alpha-Synuclein |
| AD | Alzheimer’s disease |
| AHRs | Aryl hydrocarbon receptors |
| ALS | Amyotrophic lateral sclerosis |
| AMPA | α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| ATP | Adenosine triphosphate |
| BBB | Blood-brain barrier |
| CA | Cinnabarinic acid |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| DA | Dopamine |
| DOPAC | 3,4-Dihydroxyphenylacetic acid |
| EAE | Experimental autoimmune encephalitis |
| FTD | Frontotemporal dementia |
| GI | Gastrointestinal |
| GPR35 | G-protein receptor 35 |
| HD | Huntington’s disease |
| IDO-1 | Indolamine 2,3-dioxygenase 1 |
| IFNs | Interferons |
| KATs | Kynurenine aminotransferases |
| KMO | Kynurenine 3-monooxygenase |
| KP | Kynurenine pathway |
| KYN | Kynurenine |
| KYNA | Kynurenic acid |
| LBs | Lewy bodies |
| l-KYN | N-formyl-l-kynurenine |
| MPP(+) | 1-Methyl-4-phenylpyridinium |
| MPTP | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MS | Multiple sclerosis |
| NAD+ | Nicotinamide adenine dinucleotide |
| NMDA | N-methyl-d-aspartate |
| PD | Parkinson’s disease |
| PIC | Picolinic acid |
| PPMS | Primary progressive MS |
| QUIN | Quinolinic acid |
| ROS | Reactive oxygen species |
| RRMS | Relapsing-remitting MS |
| SNP | Single nucleotide polymorphism |
| SNpc | Pars compacta of the substance nigra |
| TDO | Tryptophan 2,3-dioxygenase |
| TDP-43 | TAR DNA-binding protein 43 |
| TRP | Tryptophan |
| XA | Xanthurenic acid |